Ingo Tamm

4.3k total citations · 3 hit papers
42 papers, 3.4k citations indexed

About

Ingo Tamm is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Ingo Tamm has authored 42 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 14 papers in Oncology and 12 papers in Hematology. Recurrent topics in Ingo Tamm's work include Cell death mechanisms and regulation (12 papers), Cancer-related Molecular Pathways (7 papers) and Acute Myeloid Leukemia Research (7 papers). Ingo Tamm is often cited by papers focused on Cell death mechanisms and regulation (12 papers), Cancer-related Molecular Pathways (7 papers) and Acute Myeloid Leukemia Research (7 papers). Ingo Tamm collaborates with scholars based in Germany, United States and Sweden. Ingo Tamm's co-authors include Dominic A. Scudiero, Yi Wang, Tilman Oltersdorf, Edward A. Sausville, Bernd Dörken, John C. Reed, Kate Welsh, Karin Schmelz, Mandy Wagner and Nuria Assa‐Munt and has published in prestigious journals such as The Lancet, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Ingo Tamm

39 papers receiving 3.3k citations

Hit Papers

IAP-family protein survivin inhibits caspase activity and... 1998 2026 2007 2016 1998 2000 1998 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingo Tamm Germany 21 2.7k 980 541 370 355 42 3.4k
Janardhan Sampath United States 14 1.7k 0.6× 1.6k 1.6× 333 0.6× 389 1.1× 465 1.3× 16 3.1k
Thomas Chittenden United States 11 1.8k 0.7× 1.5k 1.5× 525 1.0× 328 0.9× 301 0.8× 25 3.4k
Yuji Heike Japan 27 1.4k 0.5× 1.1k 1.1× 772 1.4× 518 1.4× 463 1.3× 126 3.0k
Astrid Gruber Sweden 34 1.8k 0.7× 927 0.9× 343 0.6× 311 0.8× 643 1.8× 99 3.5k
Takatoshi Ishiko Japan 29 1.4k 0.5× 1.3k 1.4× 333 0.6× 448 1.2× 322 0.9× 141 3.4k
Laura J. Janke United States 25 1.6k 0.6× 583 0.6× 925 1.7× 272 0.7× 425 1.2× 68 2.8k
Wendy Schober United States 34 1.8k 0.7× 729 0.7× 663 1.2× 355 1.0× 751 2.1× 64 3.0k
Alexander Egle Austria 35 2.0k 0.7× 1.5k 1.5× 1.2k 2.2× 496 1.3× 586 1.7× 153 4.2k
Kylie D. Mason Australia 18 2.4k 0.9× 809 0.8× 948 1.8× 247 0.7× 908 2.6× 58 4.0k
David P. Curley United States 18 2.2k 0.8× 954 1.0× 560 1.0× 336 0.9× 1.0k 2.9× 24 3.5k

Countries citing papers authored by Ingo Tamm

Since Specialization
Citations

This map shows the geographic impact of Ingo Tamm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingo Tamm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingo Tamm more than expected).

Fields of papers citing papers by Ingo Tamm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingo Tamm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingo Tamm. The network helps show where Ingo Tamm may publish in the future.

Co-authorship network of co-authors of Ingo Tamm

This figure shows the co-authorship network connecting the top 25 collaborators of Ingo Tamm. A scholar is included among the top collaborators of Ingo Tamm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingo Tamm. Ingo Tamm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wörmann, Bernhard, et al.. (2021). Onkologie und Ökonomie – wie frei sind wir wirklich in der Behandlung von Patient*innen?. Oncology Research and Treatment. 44(Suppl. 1). 2–26. 1 indexed citations
2.
Colecchia, F., Denise Kottwitz, Mandy Wagner, et al.. (2009). Tissue-specific regulatory network extractor (TS-REX): a database and software resource for the tissue and cell type-specific investigation of transcription factor-gene networks. Nucleic Acids Research. 37(11). e82–e82. 3 indexed citations
3.
Terwey, Theis H., Gero Massenkeil, Ingo Tamm, et al.. (2008). Allogeneic SCT in refractory or relapsed adult ALL is effective without prior reinduction chemotherapy. Bone Marrow Transplantation. 42(12). 791–798. 19 indexed citations
4.
Neuburger, Stefan, Gero Massenkeil, Michael Seibold, et al.. (2008). Successful salvage treatment of disseminated cutaneous fusariosis with liposomal amphotericin B and terbinafine after allogeneic stem cell transplantation. Transplant Infectious Disease. 10(4). 290–293. 23 indexed citations
5.
Wagner, Mandy, Karin Schmelz, Bernd Dörken, & Ingo Tamm. (2008). Epigenetic and genetic analysis of the survivin promoter in acute myeloid leukemia. Leukemia Research. 32(7). 1054–1060. 36 indexed citations
6.
Wagner, Mandy, Karin Schmelz, Bernd Dörken, & Ingo Tamm. (2007). Transcriptional regulation of human survivin by early growth response (Egr)‐1 transcription factor. International Journal of Cancer. 122(6). 1278–1287. 22 indexed citations
7.
Dieing, Annette, Olaf Ahlers, Bert Hildebrandt, et al.. (2007). The effect of induced hyperthermia on the immune system. Progress in brain research. 162. 137–152. 35 indexed citations
8.
Wagner, Mandy, Karin Schmelz, Christian Wuchter, et al.. (2006). In vivo expression of survivin and its splice variant survivin‐2B: Impact on clinical outcome in acute myeloid leukemia. International Journal of Cancer. 119(6). 1291–1297. 47 indexed citations
9.
Tamm, Ingo, Mandy Wagner, & Karin Schmelz. (2005). Decitabine activates specific caspases downstream of p73 in myeloid leukemia. Annals of Hematology. 84(S1). 47–53. 20 indexed citations
10.
Massenkeil, Gero, Marion Nagy, Stefan Neuburger, et al.. (2005). Survival after reduced-intensity conditioning is not inferior to standard high-dose conditioning before allogeneic haematopoietic cell transplantation in acute leukaemias. Bone Marrow Transplantation. 36(8). 683–689. 38 indexed citations
12.
Schmelz, Karin, Thomas Wieder, Ingo Tamm, et al.. (2004). Tumor necrosis factor α sensitizes malignant cells to chemotherapeutic drugs via the mitochondrial apoptosis pathway independently of caspase-8 and NF-κB. Oncogene. 23(40). 6743–6759. 31 indexed citations
13.
Tamm, Ingo. (2004). Antisense Therapy in Clinical Oncology: Preclinical and Clinical Experiences. Humana Press eBooks. 106. 113–134. 5 indexed citations
14.
Kortsik, C., et al.. (2003). Pleural Effusion due to <i>Histoplasma capsulatum</i> and Idiopathic CD4 Lymphocytopenia. Respiration. 70(1). 118–122. 20 indexed citations
15.
Tamm, Ingo, Axel Schumacher, Leonid Karawajew, et al.. (2002). Adenovirus-mediated gene transfer of P16INK4/CDKN2 into bax-negative colon cancer cells induces apoptosis and tumor regression in vivo. Cancer Gene Therapy. 9(8). 641–650. 16 indexed citations
16.
Tamm, Ingo, et al.. (2001). Apoptosis: implications of basic research for clinical oncology. The Lancet Oncology. 2(1). 33–42. 123 indexed citations
17.
Tamm, Ingo & C. Kortsik. (1999). Severe Barium Sulfate Aspirationinto the Lung: Clinical Presentation, Prognosis and Therapy. Respiration. 66(1). 81–84. 31 indexed citations
18.
Takahashi, Ryōsuke, Quinn L. Deveraux, Ingo Tamm, et al.. (1998). A Single BIR Domain of XIAP Sufficient for Inhibiting Caspases. Journal of Biological Chemistry. 273(14). 7787–7790. 507 indexed citations breakdown →
19.
Tamm, Ingo, Elisabeth Bergen, Erwin Schöpf, et al.. (1997). Dacarbazine and Interferon Alpha for Stage IV Malignant Melanoma. Oncology. 54(4). 270–274. 5 indexed citations
20.
Lennert, K., Ingo Tamm, & Hans‐Heinrich Wacker. (1991). Histopathology and Immunocytochemistry of Lymph Node Biopsies in Chronic Lymphocytic Leukemia and Immunocytoma. Leukemia & lymphoma. 5(sup1). 157–160. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026